Total Hip Arthroplasty in Patients with Hemophilia: What Do We know?
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 37538131.
- Also identified by DOI 10.22038/ABJS.2023.58812.291 and PMC identifier 10394744.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Total hip arthroplasty (THA) is the mainstay therapy for terminally hemophilic arthropathy patients. Hemophilic patients have distinguishing characteristics, including the increased likelihood of bleeding, younger age, restricted pre-operative joint motion, disrupted anatomy, and more post-operative side effects. The present study aimed to assess the THA sequels in hemophilic patients from various perspectives, including indications, challenges, factor replacement post-operative outcomes, and other complications.
Anatomy
- hip